CSIMarket
 


Bluebird Bio Inc   (BLUE)
Other Ticker:  
 


Bluebird Bio Inc 's EBITDA Margin by quarter

Trends, Rankings, Statistics



BLUE EBITDA Margin (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Revenue Change 17353.52 % 353.59 % 22.42 % - -99.05 %
Seq. Revenue Change 79.85 % 189.37 % 3740.32 % -12.68 % -95.33 %
Revenue In Millions $12.39 $6.89 $2.38 $0.06 $0.07
EBITDA Margin -550.4 % -1006.37 % - - -105271.83 %
EBITDA Margin Total Ranking # # # 38 # 16 #
EBITDA In Millions $-68.21 $-69.34 $25.15 $33.97 $-74.74
Y / Y EBITDA Change - - - - -
Seq. EBITDA Change - - - - -


Commenting Third Quarter 2023 EBITDA Margin
Bluebird Bio Inc Operating Loss of -68 fell compare to Operating Loss of $-69.34 millions a quarter before.

Observing third quarter 2023 results within Biotechnology & Pharmaceuticals industry Bluebird Bio Inc has achieved highest EBITDA Margin. While overall EBITDA Margin ranking remained unchanged compare to previous quarter at no. .
Learn about Operating Margin
BLUE's EBITDA Margin third quarter 2023 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall # 0

EBITDA Margin Statistics
High Average Low
54785.48 % 27920.82 % 1056.15 %
(Dec 31 2022)   (Mar 31 2023)




Other EBITDA Margin Profitability Ratios
BLUE's Cumulative EBITDA Margin
Biotechnology & Pharmaceuticals Industry EBITDA Margin Trends and Statistics
Healthcare Sector EBITDA Margin Statistics
EBITDA Margin Profitability Trends for overall market
BLUE's EBITDA Margin Profitability versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking EBITDA Margin
Lowest Ranking EBITDA Margin
EBITDA Margin Profit Margin for BLUE's Competitors
EBITDA Margin Profit Margin for Bluebird Bio Inc 's Suppliers
EBITDA Margin Profit Margin for BLUE's Customers

You may also want to know
BLUE's Annual Growth Rates BLUE's Profitability Ratios BLUE's Asset Turnover Ratio BLUE's Dividend Growth
BLUE's Roe BLUE's Valuation Ratios BLUE's Financial Strength Ratios BLUE's EBITDA Growth
BLUE's Roa BLUE's Inventory Turnover Ratio BLUE's Growth Rates BLUE's Dividend Comparisons


Companies with similar EBITDA Margin in the quarter ending Sep 30 2023, within Biotechnology & Pharmaceuticals Industry EBITDA MarginSep 30 2023 MRQ EBITDASep 30 2023 MRQ Revenue




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com